Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b…
Zealand Pharma to Present Data at the American Diabetes Association’s 2026 Scientific Sessions
Press release – No. 10 / 2026 Zealand Pharma to Present Data…
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
Data spans seven presentations across both solid tumors and hematologic malignancies, providing…
Calidi Biotherapeutics Provides Required NYSE American Disclosure
May 22, 2026 18:00 ET | Source: Calidi Biotherapeutics, Inc SAN DIEGO,…
Ooma Receives Frost & Sullivan’s 2026 North American Competitive Strategy Leadership Recognition for Excellence in POTS-Replacement Solution Innovation
Recognized for its innovation and customer-oriented approach in delivering reliable, scalable POTS-replacement…
ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
April 27, 2026 17:00 ET | Source: ElevateBio – Posters detail large…
Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
April 27, 2026 17:00 ET | Source: Arbor Biotechnologies Inc - Oral…
Lumen Receives Frost & Sullivan’s 2026 North American Broadcast Video Managed Services Recognition for Excellence in Purpose-Built Broadcast Reliability and Operational Efficiency
Recognized for delivering purpose-built broadcast services that enhance operational efficiency, reliability, and…
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
ROCKVILLE, Md. and SUZHOU, China, April 19, 2026 (GLOBE NEWSWIRE) -- Ascentage…
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON”…
